Rare Disease Report

SD-809 and Huntington's Disease

APRIL 29, 2016
Samuel Franks, MD

Samuel Franks, MD of Beth Israel Deaconess medical Center discusses the efficacy of SD-809 to treat chorea and dystonia in patients with Huntington's disease.


Franks SM, Stamler D, Sung V, et al. Deutetrabenazine Effect on Total Motor Score in Patients with Huntington Disease (First-HD). Poster presented at: 68th Annual Meeting of the American Academy of Neurlogy; April 15-21, 2016; Vancouver, BC. Abstract 8695.

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.